NCT05767762

Brief Summary

Clubfoot is an orthopedic congenital malformation of the lower limb of the newborn evaluated by the Dimeglio score. There is a deficit of muscular balance between the agonists and antagonists to the deformity. The Dimeglio score takes into account the muscular activity but only up to one point out of 20. This study proposes to use a muscle scale inspired by the Dimeglio score to see if there is a correlation between muscle activity and the risk of tenotomy before 1 year. It will also assess the inter-examiner reproducibility of this scale. This study is a prospective cohort study with a duration of 8 years to include about 100 feet. Infants with idiopathic Clubfoot treated with the functional method at up to 15 days of life will be included. Feet will be assessed at an inclusion visit and then at 3-6-12 months. The primary endpoint will be the need for Achilles tenotomy before 1 year of age. The secondary endpoint will be inter-examiner reproducibility determined by statistical analysis. The expectation of this study would be to define a predictive factor of the evolution of the PBVE in order to refine the treatment earlier.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
68mo left

Started Apr 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress35%
Apr 2023Dec 2031

First Submitted

Initial submission to the registry

March 2, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 14, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

April 26, 2023

Completed
7.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2031

Expected
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2031

Last Updated

September 29, 2023

Status Verified

March 1, 2023

Enrollment Period

7.9 years

First QC Date

March 2, 2023

Last Update Submit

September 28, 2023

Conditions

Keywords

Muscle activityscaleAchilles tenotomy

Outcome Measures

Primary Outcomes (1)

  • Surgery

    number of patient who need for Achilles tenotomy

    maximum 1 year after inclusion

Secondary Outcomes (1)

  • Inter-examiner reproducibility

    through study completion, an average of 8 years

Study Arms (1)

Idiopathic Clubfoot

EXPERIMENTAL
Other: scale Idiopathic Clubfoot

Interventions

The Dimeglo and the muscle activity scale will be performed at 3, 6 and 12 months with patient with idiopathic clubfoot

Idiopathic Clubfoot

Eligibility Criteria

Age0 Months - 12 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • idiopathic clubfoot, managed by the functional method, managed before D15 to perform the initial assessment.

You may not qualify if:

  • syndromic clubfoot, management other than functional method, management after D15

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopitaux Pediatriques de Nice Chu-Lenval

Nice, 60200, France

RECRUITING

MeSH Terms

Conditions

Clubfoot

Condition Hierarchy (Ancestors)

TalipesFoot Deformities, AcquiredFoot DeformitiesMusculoskeletal DiseasesFoot Deformities, CongenitalLower Extremity Deformities, CongenitalLimb Deformities, CongenitalMusculoskeletal AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Central Study Contacts

Grégoire Peuchevrier

CONTACT

Dominique Donzeau

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 2, 2023

First Posted

March 14, 2023

Study Start

April 26, 2023

Primary Completion (Estimated)

March 1, 2031

Study Completion (Estimated)

December 1, 2031

Last Updated

September 29, 2023

Record last verified: 2023-03

Locations